Induction of Clinical Response Using Rifaximin in Crohn's Disease
This study is currently recruiting participants.
Verified May 2017 by Scott Lee, University of Washington
Valeant Pharmaceuticals International, Inc.
Information provided by (Responsible Party):
Scott Lee, University of Washington
First received: January 16, 2008
Last updated: May 15, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2017|
|Estimated Primary Completion Date:||December 2017 (Final data collection date for primary outcome measure)|